Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Radezolid> ?p ?o. }
Showing items 1 to 57 of
57
with 100 items per page.
- Radezolid abstract "Radezolid (INN, codenamed RX-1741) is a novel oxazolidinone antibiotic being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. Radezolid has completed two phase-II clinical trials. One of these clinical trials was for uncomplicated skin and skin-structure infections (uSSSI) and the other clinical trial was for community acquired pneumonia (CAP).".
- Radezolid atcPrefix "none".
- Radezolid casNumber "869884-78-6".
- Radezolid fdaUniiCode "53PC6LO35W".
- Radezolid iupacName "N-{[(5S)-3-(2-fluoro-4′-{[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl}biphenyl-4-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide".
- Radezolid pubchem "11224409".
- Radezolid thumbnail Radezolid.svg?width=300.
- Radezolid wikiPageExternalLink rx_1741.
- Radezolid wikiPageID "25435686".
- Radezolid wikiPageRevisionID "592892494".
- Radezolid alt "Skeletal formula of radezolid".
- Radezolid atcPrefix "none".
- Radezolid c "22".
- Radezolid casNumber "869884".
- Radezolid chembl "455461".
- Radezolid chemspiderid "9399462".
- Radezolid f "1".
- Radezolid h "23".
- Radezolid hasPhotoCollection Radezolid.
- Radezolid iupacName "N-{[-3--2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide".
- Radezolid legalStatus "Investigational".
- Radezolid molecularWeight "438.455".
- Radezolid n "6".
- Radezolid o "3".
- Radezolid pubchem "11224409".
- Radezolid routesOfAdministration "Intravenous infusion, oral".
- Radezolid smiles "CCNC[C@H]1CNc2cccc3cccCNCc4cnn[nH]4".
- Radezolid unii "53".
- Radezolid subject Category:Acetamides.
- Radezolid subject Category:Organofluorides.
- Radezolid subject Category:Oxazolidinone_antibiotics.
- Radezolid subject Category:Triazoles.
- Radezolid type Abstraction100002137.
- Radezolid type Acetamide114711197.
- Radezolid type Acetamides.
- Radezolid type Amide114724264.
- Radezolid type Chemical114806838.
- Radezolid type Compound114818238.
- Radezolid type Material114580897.
- Radezolid type Matter100020827.
- Radezolid type OrganicCompound114727670.
- Radezolid type Part113809207.
- Radezolid type PhysicalEntity100001930.
- Radezolid type Relation100031921.
- Radezolid type Substance100019613.
- Radezolid type Drug.
- Radezolid type DrugProduct.
- Radezolid type FunctionalSubstance.
- Radezolid comment "Radezolid (INN, codenamed RX-1741) is a novel oxazolidinone antibiotic being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. Radezolid has completed two phase-II clinical trials. One of these clinical trials was for uncomplicated skin and skin-structure infections (uSSSI) and the other clinical trial was for community acquired pneumonia (CAP).".
- Radezolid label "Radezolid".
- Radezolid sameAs m.09k5z_x.
- Radezolid sameAs Q7280139.
- Radezolid sameAs Q7280139.
- Radezolid sameAs Radezolid.
- Radezolid wasDerivedFrom Radezolid?oldid=592892494.
- Radezolid depiction Radezolid.svg.
- Radezolid isPrimaryTopicOf Radezolid.